Elanco Animal Health Inc. was sued by a former attorney who says the company discriminated against her based on her sex when it failed to promote her to the Head of Intellectual Property position and ...

Even a juggernaut like Eli Lilly ( LLY 2.71%) can miss the mark sometimes. When it reported its third-quarter earnings on Oct. 30, its share price plunged to the tune of 11% before recovering somewhat ...

Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...

Ricks is being recognized for his contributions to Indiana’s life sciences sector and his global impact on health care ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 593.18% and ...

Shares of Eli Lilly have gained considerably throughout 2024, thanks in large part to the company's success in diabetes and obesity care. Outside of weight loss, Eli Lilly has a major opportunity ...

Eli Lilly has thrown its weight behind a cause beyond the traditional remit of pharma companies. As the sponsor of an app for finding public restrooms, the Big Pharma is shining a light on just ...

The company is working with OpenAI to help develop new medications to combat antimicrobial resistance (AMR). At a high level, ...

2. The company is increasing capacity, which should accelerate growth A big hindrance for Eli Lilly these days is capacity. Demand is soaring for Mounjaro and Zepbound, which has led to people ...